The Cure for Restructuring Ills: Fasken Martineau a finalist for "Restructuring deals and Team of the year" for pharmaceutical matters at the IFLR Americas Awards
February 7, 2012
Vancouver (Canada) – Fasken Martineau, a leading international business law and litigation firm, announced today that its Insolvency & Restructuring and Life Sciences groups are finalists in the annual IFLR Americas Awards.
Fasken Martineau is nominated in three categories:
Restructuring Deal of the year –
Angiotech Pharmaceuticals Restructuring Deal of the year –
Graceway Pharmaceuticals Restructuring Team of the year.
"Fasken Martineau offers clients the most skilled and knowledgeable lawyers in restructuring and insolvency, both in Canada and abroad. This recognition from our peers is rewarding, but our greatest satisfaction comes from giving the best advice to our clients," said
John Grieve, leader of the firm's Insolvency & Restructuring group.
"We have made a name for ourselves in the life science industry, so being nominated for our work on restructuring deals for pharmaceutical clients is a great achievement," said
Louis-François Hogue, leader of Fasken Martineau's Life Sciences group.
The IFLR Americas Awards Ceremony will be held in New York City on March 29, 2012.
About Fasken Martineau DuMoulin LLP
Fasken Martineau is a leading international business law and litigation firm. With over 675 lawyers, the firm has offices in Vancouver, Calgary, Toronto, Ottawa, Montréal, Québec City, London, Paris and Johannesburg. For additional information, please visit the firm's website at
www.fasken.com.